[1]. Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C. Inhibition of Periostin Expression Protects against the Development of Renal Inflammation and Fibrosis. J Am Soc Nephrol. 2014; 25:1724-1736. doi: 10.1681/ASN.2013060664.
[2]. Su H, Wan C, Song AN, Qiu Y, Xiong W, Zhang C. Oxidative Stress and Renal Fibrosis: Mechanisms and Therapies. Adv Exp Med Biol. 2019; 1165:585-604. doi: 10.1007/978-981-13-8871-2_29.
[3]. Meng XM, Chung AC, Lan HY. Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci. 2013; 124:243–254. doi: 10.1042/CS20120252.
[4]. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002; 13:2600–2610. doi: 10.1097/01.asn.0000033611.79556. ae.
[5]. Higgins SP, Tang Y, Higgins CE, Mian B, Zhang W, Czekay RP, Samarakoon R, Conti DJ, Higgins PJ. TGF-β1/p53 signaling in renal fibrogenesis. Cell Signal. 2018; 43:1-10. doi: 10.1016/j.cellsig.2017.11.005.
[6]. Kim JH, Kim BK, Moon KC, Hong HK, Lee HS. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int. 2003; 64:1715–1721. doi: 10.1046/j.1523-1755.2003.00288. x.
[7]. Poncelet AC, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2001; 276:6983-6992. doi: 10.1074/jbc.M006442200.
[8]. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012; 81:145e166. doi: 10.1146/annurev-biochem-051410-092902.
[9]. Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990; 10:28–36. doi: 10.1128/mcb.10.1.28.
[10]. Moghaddas Sani H, Hejazian M, Hosseinian Khatibi SM, Ardalan M, Zununi Vahed S. Long non-coding RNAs: an essential emerging field in kidney pathogenesis. Biomed Pharmacother. 2018; 99:755–765. doi: 10.1016/j.biopha.2018.01.122.
[11]. Liu ZW, Wang Y, Shu SQ, Cai J, Tang CY, Dong Z. Non-coding RNAs in kidney injury and repair. Am J Physiol Cell Physiol. 2019; 317:177-188. doi: 10.1152/ajpcell.00048.2019.
[12]. Chen W, Zhou ZQ, Ren YQ, Zhang L, Sun LN, Man YL, Wang ZK. Effects of long non-coding RNA LINC00667 on renal tubular epithelial cell proliferation, apoptosis and renal fibrosis via the miR-19b-3p/LINC00667/CTGF signaling pathway in chronic renal failure. Cell Signal. 2019; 54:102–114. doi: 10.1016/j.cellsig.2018.10.016.
[13]. Sun SF, Tang PMK, Feng M, Xiao J, Huang XR, Li P, Ma RCW, Lan HY. Novel lncRNA Erbb4-IR promotes diabetic kidney injury in db/db mice by targeting miR-29b. Diabetes. 2018;67: 731–744. doi: 10.2337/db17-0816.
[14]. Yu MY, Guan Z, Li SW, Wen XL, Shi HM, Qu GT, Lu XY, Zhu XY, Wang B, Feng QH, Gan WH, Zhang AQ. Gene expression profiling analysis reveals that the long non-coding RNA uc.412 is involved in mesangial cell proliferation. Mol Med Rep. 2019; 20:5297–5303. doi: 10.3892/mmr.2019.10753.
[15]. Wang B, Xu X, He X, Wang Z and Yang M. Berberine improved aldo‑induced podocyte injury via inhibiting oxidative stress and endoplasmic reticulum stress pathways both in vivo and in vitro. Cell Physiol Biochem 39: 217‑228, 2016. doi: 10.1159/000445618.
[16]. Piskounova E, Viswanathan SR, Janas M, LaPierre RJ, Daley GQ, Sliz P, Gregory RI. Determinants of microRNA processing inhibition by the developmentally regulated RNA binding protein Lin28. J Biol Chem. 2008; 283:21310-21314. doi: 10.1074/jbc.C800108200.
[17]. Wang X, Chaudhry MA, Nie Y, Xie Z, Shapiro JI, Liu J. A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy. J Vis Exp. 2013; 77: e50398. doi: 10.3791/55825.
[18]. Xu Z, Yang F, Wei D, Wang L. Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma. Oncogene. 2017;36;1965–1977. doi: 10.1038/onc.2016.356.
[19]. He F, Song Z, Chen H, Cao J. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128. Oncogene. 2019; 38;164–179. doi: 10.1038/s41388-018-0432-8.
[20]. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017; 389:1238-1252. doi: 10.1016/S0140-6736(16)32064-5.
[21]. Zhao JH. Mesangial Cells and Renal Fibrosis. Adv Exp Med Biol. 2019; 1165:165-194. doi: 10.1007/978-981-13-8871-2_9.
[22]. Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016; 12:325-338. doi: 10.1038/nrneph.2016.48.
[23]. Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017; 91:1014-1021. doi: 10.1016/j.kint.2017.02.003.
[24]. Ma TT, Meng XM. TGF-β/Smad and Renal Fibrosis. Adv Exp Med Biol. 2019; 1165:347-364. doi: 10.1007/978-981-13-8871-2_16.
[25]. Kurosu1 T, Ohga N. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium. Br J Cancer. 2011;104: 819-829. doi: 10.1038/bjc.2011.20.
[26]. Vlasova-St Louis I, Bohjanen PR. Feedback Regulation of Kinase Signaling Pathways by AREs and GREs. Cells. 2016; 5:4. doi: 10.3390/cells5010004.
[27]. Shang J, Zhao ZZ. Emerging role of HuR in inflammatory response in kidney diseases. Acta Biochim Biophys Sin. 2017; 49:753-763. doi: 10.1093/abbs/gmx071.
[28]. LaJevic MD, Koduvayur SP, Caffrey V, Cohen RL, Chambers DA. Thy-1 mRNA destabilization by norepinephrine a 3′UTR cAMP responsive decay element and involves RNA binding proteins. Brain Behav Immun. 2010; 24:1078–1088. doi: 10.1016/j.bbi.2010.04.006.
[29]. Liao WL, Wang WC, Chang WC, Tseng JT. The RNA-binding protein HuR stabilizes cytosolic phospholipase A2alpha mRNA under interleukin-1beta treatment in non-small cell lung cancer A549 Cells. J Biol Chem. 2011; 286:35499–35508. doi: 10.1074/jbc.M111.263582.
[30]. Doller A, Schlepckow K, Schwalbe H, Pfeilschifter J, Eberhardt W. Tandem phosphorylation of serines 221 and 318 by protein kinase Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling of HuR. Mol Cell Biol. 2010; 30:1397–1410. doi: 10.1128/MCB.01373-09.
[31]. Shi Q, Lee DY, Féliers D, Abboud HE, Bhat MA, Gorin Y. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease. Mol Metab. 2020; 36:100968. doi: 10.1016/j.molmet.2020.02.011.